Targeted therapy can be used for melanomas with a damaged BRAF gene. Testing the tumour can determine if the BRAF gene is normal or damaged. Zelboraf (vemurafenib) is an oral targeted therapy for people with advanced melanoma with a damaged BRAF gene. This treatment can be given as an initial therapy for people with extensive melanoma.
Targeted Therapy Side Effects
Side effects of Zelboraf include extreme sun sensitivity, joint pain and swelling, and skin cancer. If you receive Zelboraf, you will need to have regular skin examinations and see a dermatologist if you develop symptoms.